Navigation Links
Neuronascent to Present at Life Sciences Summit 2009
Date:9/15/2009

CLARKSVILLE, Md.., Sept. 15 /PRNewswire/ -- Neuronascent, Inc., a privately-held biotechnology company developing novel, neurogenic small-molecule drugs for the treatment of depression, Alzheimer's, Parkinson's and other neurodegenerative diseases, today announced that Dr. Judith Kelleher-Andersson, President and Chief Scientific Officer, will present at the Life Sciences Summit 2009 -- Showcasing Innovation, Promoting Collaboration. The Summit brings the world's leading companies together with the world's most innovative scientists to explore the next generation of biomedical solutions, the proceeds from which will help seed a bio-innovation research fund to support the discovery, development, translation, and commercialization of these new technologies. The event will take place on September 23-24, 2009 at Hyatt Regency Long Island in Hauppauge, New York.

"We are proud to have been selected to showcase the potential of our first-in-class CNS drug candidates and our neurogenesis platform," said Dr. Kelleher-Andersson. "Our participation in the Summit, with the nation's leading research institutions and top bioscience companies, supports our strategy for collaboration and innovation combining the best of business and the best of science."

About Neuronascent, Inc.:

Founded in 2004 by Dr. Judith Kelleher-Andersson, Neuronascent, discovers and develops first-in-class, small-molecule therapeutics, based on the science of neurogenesis, that target depression and neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The Company is headquartered in Clarksville, MD and has facilities in Rockville and Walkersville, MD. For additional information, please visit www.neuronascent.com.

About The Center for Biotechnology, A New York State Center for Advanced Technology in Medical Biotechnology:

The Center for Biotechnology is a cooperative research and development partnership between universities, private industry and New York State. Located on the campus of Stony Brook University, the Center's technology development initiative has contributed to an active pipeline of more than forty commercially promising technologies, the commercialization of more than a dozen novel biomedical products, and the formation of eighteen new bioscience companies. The Center is funded by the New York Office of Science, Technology and Academic Research (NYSTAR). Visit www.biotech.sunysb.edu for more information on the Center.


'/>"/>
SOURCE Neuronascent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Martek to Present at Two Upcoming Investor Conferences
2. ViroPharma to Present at Four Additional Healthcare Conferences
3. Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009
4. ERT to Present at UBS Global Life Sciences Conference on September 21, 2009
5. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
6. NovaBay(R) Presents Data Confirming Its Aganocide(R) Compounds Are Effective In Killing Bacteria That Have Developed Multidrug-Resistance
7. aTyr Pharma to Present at BioPharm America 2009
8. CryoLife to Present at UBS Global Life Sciences Conference
9. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting
10. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Enox Biopharma Will Present Its Unique Self-Sterilizing Urinary Catheter at the 49th Annual ICAAC Meeting.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... a company focused on discovery and development of precision treatments for neurodegenerative ... developing for Alzheimer’s disease (AD) inhibited the direct neurotoxic effect of prion-like ...
(Date:12/5/2016)... Dec. 5, 2016 Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced that ... treatment of Alzheimer,s disease will be presented at the ... Friday, December 9, 2016 in San Diego ... of both simple and complex measures of activities of ...
(Date:12/5/2016)... Research and Markets has announced the addition of Jain ... to their offering. ... , This report describes different ... as proteomics and metabolomics. Molecular diagnostics technologies are used for the ... Currently the most important applications of biomarkers are in ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... MA to soon resume cervical and lumbar disc production, company President, Jake Lubinski ... surgeons who are implanting the AxioMed disc in Cologne and Karlsruhe to discuss ...
Breaking Biology Technology:
(Date:11/30/2016)... CHICAGO , Nov. 30, 2016  higi ... a new partnership initiative targeting national brands, industry ... and reward their respective audiences for taking steps ... Since its inception in 2012, higi has built ... US, impacting over 38 million people who have ...
(Date:11/24/2016)... Nov. 23, 2016 Cercacor today introduced Ember ... their trainers non-invasively measure hemoglobin, Oxygen Content, ... and Respiration Rate in approximately 30 seconds. Smaller than ... and immediate access to key data about their bodies ... training regimen. Hemoglobin carries oxygen to ...
(Date:11/17/2016)... 2016 Global Market Watch: Primarily supported ... Population-Based Banks and Academics) market is to witness a value ... shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% ... the analysis period 2014-2020. North America ... by Europe at 9.56% respectively. ...
Breaking Biology News(10 mins):